Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Public ClinicalTrials.gov record NCT01764841. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Study identification
- NCT ID
- NCT01764841
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bayer
- Industry
- Enrollment
- 416 participants
Conditions and interventions
Conditions
Interventions
- Ciprofloxacin DPI (BAYQ3939) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 1, 2013
- Primary completion
- Mar 8, 2016
- Completion
- Mar 8, 2016
- Last update posted
- Jan 23, 2018
2013 – 2016
United States locations
- U.S. sites
- 39
- U.S. states
- 20
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Jasper | Alabama | 35501 | — |
| Not listed | Flagstaff | Arizona | 86001 | — |
| Not listed | Phoenix | Arizona | 85006-2611 | — |
| Not listed | Scottsdale | Arizona | 85258 | — |
| Not listed | Fort Smith | Arkansas | 72901 | — |
| Not listed | Los Angeles | California | 90048 | — |
| Not listed | Torrance | California | — | — |
| Not listed | Ventura | California | 93003 | — |
| Not listed | Farmington | Connecticut | 06030 | — |
| Not listed | Waterbury | Connecticut | 06708-2513 | — |
| Not listed | Washington D.C. | District of Columbia | 20007-2197 | — |
| Not listed | Celebration | Florida | 34747 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Orlando | Florida | 32803 | — |
| Not listed | Weston | Florida | 33331 | — |
| Not listed | Winter Park | Florida | 32789 | — |
| Not listed | Lawrenceville | Georgia | 30046 | — |
| Not listed | Marietta | Georgia | 30060 | — |
| Not listed | Chicago | Illinois | 60637 | — |
| Not listed | Michigan City | Indiana | 46360 | — |
| Not listed | Hazard | Kentucky | 41701 | — |
| Not listed | Chesterfield | Missouri | 63017 | — |
| Not listed | Summit | New Jersey | 07901 | — |
| Not listed | New Hyde Park | New York | 11042 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | Portland | Oregon | 97239-3011 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Philadelphia | Pennsylvania | 19140 | — |
| Not listed | Charleston | South Carolina | 29425 | — |
| Not listed | Fort Worth | Texas | 76104 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Houston | Texas | 77043 | — |
| Not listed | Kingwood | Texas | 77339 | — |
| Not listed | McKinney | Texas | 75069 | — |
| Not listed | Tyler | Texas | 75708-3154 | — |
| Not listed | Abingdon | Virginia | 24210 | — |
| Not listed | Richmond | Virginia | 23225 | — |
| Not listed | Spokane | Washington | 99202-1334 | — |
| Not listed | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 112 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01764841, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 23, 2018 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01764841 live on ClinicalTrials.gov.